Hyperkeratosis of the nipple is an uncommon, benign, asymptomatic, acquired condition of unknown pathogenesis. Most cases are bilateral, although unilateral cases had been reported. Breastfeeding is usually not affected. Physiologic changes of the nipple and areola during pregnancy include enlargement, hyperpigmentation, secondary areolae, erectile nipples, prominence of veins, striae, and enlargement of the Montgomery glands or tubercles (hypertrophied sebaceous glands). Women with unilateral primary hyperkeratosis of the nipple and/or areola (HNA) may have bilateral disease during pregnancy (secondary HNA). Pregnancy may also produce thicker, darker lesions. Here, we report a case of pregnancy-associated hyperkeratosis of the nipple in a primigravida. We counseled her about the benign nature of the condition and treated her with topical steroids and moisturizers.
introduCtion
Hyperkeratosis of the nipple can develop as an idiopathic isolated condition or secondary in inflammatory diseases such as atopic dermatitis; in acanthosis nigricans, as an extension of epidermal nevus, after estrogen treatment; and/ or in nevoid hyperkeratosis of the nipple and areola (HNA). Pregnancy-associated hyperkeratosis of the nipple can be asymptomatic and may persist in the postpartum period. The characteristic clinical and histopathological features of this disorder allow differentiation from various dermatoses. Removal of these lesions by cautery, radiofrequency ablation, or laser is curative.
[1]
Case rePort
A 22-year-old primigravida, in her third trimester, presented with an asymptomatic, hyperpigmented warty growth over both nipples for 4 months. There was a gradual increase in the size of the lesion for the last 1 month. The patient was concerned about the increase in the size of growth and was worried about the effect on breastfeeding.
Examination revealed focal, yellow-to-tan-colored, hyperpigmented, verrucous plaques with filiform or papillomatous projection with warty surface over both nipples [ Figures 1-3] . The patient did not give consent for biopsy. We made a clinical diagnosis of pregnancy-associated hyperkeratosis of the nipple. The patient was counseled about the benign nature of the condition. She was prescribed topical mid-potent steroid (mometasone furoate ointment 0.1%) and moisturizers.
disCussion
Physiologic changes of the nipple and areola during pregnancy include enlargement, hyperpigmentation, secondary areolae, erectile nipples, prominence of veins, striae, and enlargement of the Montgomery glands or tubercles (hypertrophied sebaceous gland). [2, 3] During gestation, benign tumors (seborrheic keratosis), skin tags, warts, atopic dermatitis, [4] and conditions associated with HNA (acanthosis nigricans, ichthyosis, and Darier disease) can develop over the nipple. [5, 6] HNA is typically diagnosed in females between puberty and the third decade of life. The lesions of HNA are confluent and verrucous, and their distribution is usually bilateral. [7] Although HNA can worsen and become bilateral in pregnancy, [8, 9] its onset during or immediately after pregnancy has been only exceptionally reported. [6] [7] [8] [9] [10] It has been postulated that endocrine factors may be involved in the etiopathogenesis of HNA because the lesions worsen in pregnancy and have been associated with estrogen therapy. [11] [12] [13] The onset of HNA is usually in the second or third decade of life. HNA starts only exceptionally in pregnancy, and it exclusively involves the nipple. HNA shows verrucous lesions that are hyperpigmented, confluent, and diffuse, reminiscent of a verrucous epidermal nevus. In our case, lesions were yellow to mildly tan, focal hyperkeratotic, or warty. Regarding the etiology of this disorder, it may represent a physiologic change of pregnancy. This is supported by onset during pregnancy or in the immediate postpartum period and worsening with subsequent pregnancies, which suggest an effect of high estrogen levels during pregnancy.
Treatment in our case included emollients and topical steroids which provided only mild-to-moderate response.
Treatment modalities in HNA include 6% salicylic acid gel and topical calcipotriol. The use of potent keratolytics, such as urea, under occlusion may be effective in this entity. A short course of topical tretinoin has been effective, but significant irritation and recurrence is an adverse effect.
[1] A sustained remission of HNA has been maintained with low-dose acitretin combined with calcipotriol. Surgical modalities, such as cryotherapy, [7] shave excision, surgical removal, carbon dioxide laser, and radiofrequency ablation, have been used in unresponsive cases of HNA. Symptomatic, recalcitrant lesions showed a complete response to curettage.
[1] In conclusion, our case represents a distinct clinicopathologic presentation of pregnancy-associated nipple hyperkeratosis. This disorder can be differentiated from HNA based on later onset in life, presentation during or immediately after pregnancy, more focal involvement of the nipple, and characteristic histopathological features. In the author's experience, this entity is reasonably common, whereas the onset of nevoid HNA in pregnancy has been only exceptionally reported. Because the lesions can be persistent and symptomatic, physicians should be familiar with pregnancy-associated hyperkeratosis of the nipple and able to counsel the patient appropriately on prognosis and treatment.
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